The natural product dihydrotanshinone i provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity

Veena Beri, Scott A. Wildman, Kazuro Shiomi, Ziyad F. Al-Rashid, Jonah Cheung, Terrone L. Rosenberry

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cholinergic synaptic transmission often requires extremely rapid hydrolysis of acetylcholine by acetylcholinesterase (AChE). AChE is inactivated by organophosphates (OPs) in chemical warfare nerve agents. The resulting accumulation of acetylcholine disrupts cholinergic synaptic transmission and can lead to death. A potential long-term strategy for preventing AChE inactivation by OPs is based on evidence that OPs must pass through a peripheral site or P-site near the mouth of the AChE active site gorge before reacting with a catalytic serine in an acylation site or A-site at the base of the gorge. An ultimate goal of this strategy is to design compounds that bind tightly at or near the P-site and exclude OPs from the active site while interfering minimally with the passage of acetylcholine. However, to target the AChE P-site with ligands and potential drugs that selectively restrict access, much more information must be gathered about the structure-activity relationships of ligands that bind specifically to the P-site. We apply here an inhibitor competition assay that can correctly determine whether an AChE inhibitor binds to the P-site, the A-site, or both sites. We have used this assay to examine three uncharged, natural product inhibitors of AChE, including aflatoxin B1, dihydrotanshinone I, and territrem B. The first two of these inhibitors are predicted by the competition assay to bind selectively to the P-site, while territrem B is predicted to span both the P- and A-sites. These predictions have recently been confirmed by X-ray crystallography. Dihydrotanshinone I, with an observed binding constant (KI) of 750 nM, provides a good lead compound for the development of high-affinity, uncharged inhibitors with specificity for the P-site.

Original languageEnglish (US)
Pages (from-to)7486-7499
Number of pages14
JournalBiochemistry
Volume52
Issue number42
DOIs
StatePublished - 2013

Fingerprint

Acetylcholinesterase
Biological Products
Organophosphates
Acetylcholine
Assays
Cholinesterase Inhibitors
Synaptic Transmission
Cholinergic Agents
Catalytic Domain
Chemical Warfare Agents
Chemical warfare
Ligands
Lead compounds
Acylation
Aflatoxin B1
X ray crystallography
X Ray Crystallography
Structure-Activity Relationship
Serine
Mouth

ASJC Scopus subject areas

  • Biochemistry

Cite this

The natural product dihydrotanshinone i provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity. / Beri, Veena; Wildman, Scott A.; Shiomi, Kazuro; Al-Rashid, Ziyad F.; Cheung, Jonah; Rosenberry, Terrone L.

In: Biochemistry, Vol. 52, No. 42, 2013, p. 7486-7499.

Research output: Contribution to journalArticle

Beri, Veena ; Wildman, Scott A. ; Shiomi, Kazuro ; Al-Rashid, Ziyad F. ; Cheung, Jonah ; Rosenberry, Terrone L. / The natural product dihydrotanshinone i provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity. In: Biochemistry. 2013 ; Vol. 52, No. 42. pp. 7486-7499.
@article{1cac8339482b4f74a05f26bb17bd33ad,
title = "The natural product dihydrotanshinone i provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity",
abstract = "Cholinergic synaptic transmission often requires extremely rapid hydrolysis of acetylcholine by acetylcholinesterase (AChE). AChE is inactivated by organophosphates (OPs) in chemical warfare nerve agents. The resulting accumulation of acetylcholine disrupts cholinergic synaptic transmission and can lead to death. A potential long-term strategy for preventing AChE inactivation by OPs is based on evidence that OPs must pass through a peripheral site or P-site near the mouth of the AChE active site gorge before reacting with a catalytic serine in an acylation site or A-site at the base of the gorge. An ultimate goal of this strategy is to design compounds that bind tightly at or near the P-site and exclude OPs from the active site while interfering minimally with the passage of acetylcholine. However, to target the AChE P-site with ligands and potential drugs that selectively restrict access, much more information must be gathered about the structure-activity relationships of ligands that bind specifically to the P-site. We apply here an inhibitor competition assay that can correctly determine whether an AChE inhibitor binds to the P-site, the A-site, or both sites. We have used this assay to examine three uncharged, natural product inhibitors of AChE, including aflatoxin B1, dihydrotanshinone I, and territrem B. The first two of these inhibitors are predicted by the competition assay to bind selectively to the P-site, while territrem B is predicted to span both the P- and A-sites. These predictions have recently been confirmed by X-ray crystallography. Dihydrotanshinone I, with an observed binding constant (KI) of 750 nM, provides a good lead compound for the development of high-affinity, uncharged inhibitors with specificity for the P-site.",
author = "Veena Beri and Wildman, {Scott A.} and Kazuro Shiomi and Al-Rashid, {Ziyad F.} and Jonah Cheung and Rosenberry, {Terrone L.}",
year = "2013",
doi = "10.1021/bi401043w",
language = "English (US)",
volume = "52",
pages = "7486--7499",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "42",

}

TY - JOUR

T1 - The natural product dihydrotanshinone i provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity

AU - Beri, Veena

AU - Wildman, Scott A.

AU - Shiomi, Kazuro

AU - Al-Rashid, Ziyad F.

AU - Cheung, Jonah

AU - Rosenberry, Terrone L.

PY - 2013

Y1 - 2013

N2 - Cholinergic synaptic transmission often requires extremely rapid hydrolysis of acetylcholine by acetylcholinesterase (AChE). AChE is inactivated by organophosphates (OPs) in chemical warfare nerve agents. The resulting accumulation of acetylcholine disrupts cholinergic synaptic transmission and can lead to death. A potential long-term strategy for preventing AChE inactivation by OPs is based on evidence that OPs must pass through a peripheral site or P-site near the mouth of the AChE active site gorge before reacting with a catalytic serine in an acylation site or A-site at the base of the gorge. An ultimate goal of this strategy is to design compounds that bind tightly at or near the P-site and exclude OPs from the active site while interfering minimally with the passage of acetylcholine. However, to target the AChE P-site with ligands and potential drugs that selectively restrict access, much more information must be gathered about the structure-activity relationships of ligands that bind specifically to the P-site. We apply here an inhibitor competition assay that can correctly determine whether an AChE inhibitor binds to the P-site, the A-site, or both sites. We have used this assay to examine three uncharged, natural product inhibitors of AChE, including aflatoxin B1, dihydrotanshinone I, and territrem B. The first two of these inhibitors are predicted by the competition assay to bind selectively to the P-site, while territrem B is predicted to span both the P- and A-sites. These predictions have recently been confirmed by X-ray crystallography. Dihydrotanshinone I, with an observed binding constant (KI) of 750 nM, provides a good lead compound for the development of high-affinity, uncharged inhibitors with specificity for the P-site.

AB - Cholinergic synaptic transmission often requires extremely rapid hydrolysis of acetylcholine by acetylcholinesterase (AChE). AChE is inactivated by organophosphates (OPs) in chemical warfare nerve agents. The resulting accumulation of acetylcholine disrupts cholinergic synaptic transmission and can lead to death. A potential long-term strategy for preventing AChE inactivation by OPs is based on evidence that OPs must pass through a peripheral site or P-site near the mouth of the AChE active site gorge before reacting with a catalytic serine in an acylation site or A-site at the base of the gorge. An ultimate goal of this strategy is to design compounds that bind tightly at or near the P-site and exclude OPs from the active site while interfering minimally with the passage of acetylcholine. However, to target the AChE P-site with ligands and potential drugs that selectively restrict access, much more information must be gathered about the structure-activity relationships of ligands that bind specifically to the P-site. We apply here an inhibitor competition assay that can correctly determine whether an AChE inhibitor binds to the P-site, the A-site, or both sites. We have used this assay to examine three uncharged, natural product inhibitors of AChE, including aflatoxin B1, dihydrotanshinone I, and territrem B. The first two of these inhibitors are predicted by the competition assay to bind selectively to the P-site, while territrem B is predicted to span both the P- and A-sites. These predictions have recently been confirmed by X-ray crystallography. Dihydrotanshinone I, with an observed binding constant (KI) of 750 nM, provides a good lead compound for the development of high-affinity, uncharged inhibitors with specificity for the P-site.

UR - http://www.scopus.com/inward/record.url?scp=84886789235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886789235&partnerID=8YFLogxK

U2 - 10.1021/bi401043w

DO - 10.1021/bi401043w

M3 - Article

C2 - 24040835

AN - SCOPUS:84886789235

VL - 52

SP - 7486

EP - 7499

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 42

ER -